Investor Relations

Contact Us

Corporate Contact Investor Relations Human Resources General Inquiries

FINANCIAL RESULTS
Online Annual Report 2017
Explore report
TUBERCULOSIS
"Our goal is to develop easy and quick tests"
Read Interview
Tuberculosis
Fighting a common and persistent killer
Read Story
QIAGENcares
Battling infectious diseases
Read Story

Latest press releases

SUBSCRIBE TO RSS-FEED

23.05.2018
QIAGEN launches the DNeasy PowerSoil Pro Kit to advance microbiome characterization in soils
READ MORE
22.05.2018
QIAGEN welcomes WHO’s Essential Diagnostics List which includes QuantiFERON-TB Gold
READ MORE
15.05.2018
Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase
READ MORE
02.05.2018
QIAGEN reports results for first quarter 2018
READ MORE
20.04.2018
QIAGEN announces FDA approval of PartoSure
READ MORE
19.04.2018
QIAGEN announces European launch of QIAstat-Dx, a next generation platform for syndromic insights
READ MORE
12.04.2018
QIAGEN launches AdnaTest liquid biopsy kits in prostate and lung cancer
READ MORE
14.03.2018
QIAGEN’s QuantiFERON-TB® Gold Plus gains endorsement for latent tuberculosis screening in immigration
READ MORE
12.03.2018
QIAGEN and Natera partner to develop cutting-edge genetic testing assays for use on QIAGEN’s GeneReader NGS System
READ MORE
05.03.2018
QIAGEN launches CE-IVD assay to detect Trichomonas vaginalis in both female and male patients on the QIAsymphony RGQ platform
READ MORE

SEE ALL RELEASES

At a glance

Key figures teaser

Key figures

Strategy teaser

Strategy

IR - Share data teaser

Share data

Shareholder structure

Corporate calendar

SEE ALL EVENTS

Financial reports

SEE ALL REPORTS

Our social media channels

Visit our Social Hub

Do you have further questions?

SOCIAL SHARING

LANGUAGE

OTHER WEBSITES

© QIAGEN 2013 - 18. All rights reserved